실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
568누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-13 · 마지막 7월 13일
CGTBiologicGlaxoSmithKlinePhase 2

Eltrombopag (Eltrombopag)

Immune Thrombocytopenic Purpura · Chronic Granulomatous Disease (CGD)

#ChronicGranulomatousDiseaseCGD#CGT#Phase2#인기#세포유전치료+5
효능 ORR 10%임상시험 53상태 ACTIVE
CGTBiologicKitevedotin plus bendamustine a…Approved

axicabtagene ciloleucel (Yescarta, axi-cel)

Large B-cell Lymphoma; Lymphoma, B-Cell · FRα

#FR#CGT#Approved#인기#세포유전치료+5
효능 ORR 92%임상시험 53상태 RECRUITING
CGTBiologicHebei Senlang Biotechnology Inc…Preclinical

CD19+CD22 CAR-T (CD19+CD22 CAR-T)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#인기#세포유전치료+5
임상시험 53상태 ACTIVE
ADCBiologicVadim S Koshkinvedotin (BT8009) and dual-A…Phase 1

N803 (Nogapendekin Alfa Inbakicept, Nogapendekin Alfa Inbakicept (N803))

Metastatic Urothelial Carcinoma; Urothelial Carcinoma · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 80%임상시험 53상태 DISCONTINUED
ADCBiologicJiangsu HengRui Medicine Co., L…Phase 2

Famitinib (Famitinib)

Advanced Breast Cancer; Metastatic Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 53상태 RECRUITING
ADCBiologicGilead Sciencesderuxtecan (OR 4Phase 3

Idelalisib (Idelalisib)

Chronic Lymphocytic Leukaemia · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 90.9%임상시험 53상태 DISCONTINUED
CGTBiologicCRISPR Therapeutics AGPhase 2

CD19-directed CAR-T cells (CD19-directed CAR-T cells)

B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 25%임상시험 53상태 ACTIVE
ADCBiologicKing Abdullah International Med…Vedotin Plus AVD versus ABV…Phase 2

ABVD (ABVD)

Classical Hodgkin Lymphoma; Hodgkin Lymphoma (Category) · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 ACTIVE
AntibodyRochePreclinical

Bevacizumab + Erlotinib (Bevacizumab + Erlotinib)

Solid Tumor; Advanced Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Preclinical#인기#항체+4
효능 ORR 72%임상시험 52상태 RECRUITING
ADCBiologicSeagenvedotin-containing regimen …Phase 2

SGN-35 (brentuximab vedotin, brentuximab vedotin (SGN-35))

Hodgkin's Lymphoma · Hodgkin's Lymphoma

#HodgkinsLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 89.5%임상시험 52상태 ACTIVE
ADCBiologicSWOG Cancer Research NetworkVedotin, and BelinostatPhase 3

Pirtobrutinib (Pirtobrutinib)

Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 66.4%임상시험 52상태 RECRUITING
ADCBiologicPfizerderuxtecan have preventive …Phase 2

lorlatinib (lorlatinib)

Non-Small Cell Lung Cancer · Cancer

#Cancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 75.8%임상시험 52상태 DISCONTINUED
ADCBiologicPfizerthatPhase 3

Inotuzumab ozogamicin (Inotuzumab ozogamicin)

Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 93.3%임상시험 52상태 RECRUITING
ADCBiologicFudan UniversityderuxtecanPhase 2

Dalpiciclib (Dalpiciclib)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+4
임상시험 52상태 RECRUITING
ADCBiologicRochevedotin, rituximab, cycloph…Phase 2

Polatuzumab (Polatuzumab)

Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 52상태 RECRUITING
AntibodyAmgenPhase 2

Evolocumab (Evolocumab)

Atherosclerotic Cardiovascular Disease; Symptomatic Atherosclerosis · Primary Hyperlipidemia and Mixed Dyslipi

#PrimaryHyperlipidemiaandMixedDys#Antibody#Phase2#인기#항체+5
효능 ORR 33.3%임상시험 52상태 ACTIVE
Antibody3D Medicines (Sichuan) Co., Ltd.Phase 2

Envafolimab (Envafolimab)

Prostate Cancer; CDK12 Gene Mutation · Prostate Cancer

#ProstateCancer#Antibody#Phase2#인기#항체+5
임상시험 52상태 RECRUITING
ADCBiologicGSKinPhase 1

Belantamab (Belantamab)

Autoimmune Diseases · Autoimmune Diseases

#AutoimmuneDiseases#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 40%임상시험 52상태 DISCONTINUED
ADCBiologicUNICANCERPhase 2

Copanlisib (Copanlisib)

Carcinoma, Squamous Cell of Head and Neck · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 51상태 DISCONTINUED
AntibodyRegeneronPhase 2

Cemiplimab REGN2810 (Cemiplimab REGN2810)

Plasma Cell Myeloma · Prostate Cancer

#ProstateCancer#Antibody#Phase2#인기#항체+5
효능 ORR 55.6%임상시험 51상태 ACTIVE
ADCBiologicBristol-Myers SquibbPhase 2

Luspatercept (Luspatercept)

Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
임상시험 51상태 RECRUITING
AntibodyJanssenderuxtecan, datopotamab der…Phase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+5
효능 ORR 4.3%임상시험 51상태 RECRUITING
AntibodyNYU Langone HealthPhase 2

belimumab (belimumab)

Rheumatic Disease · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#Antibody#Phase2#인기#항체+5
효능 ORR 48.4%임상시험 51상태 RECRUITING
AntibodySeagenvedotin-containing regimen …Phase 2

Brentuximab (Brentuximab)

Diffuse Large B Cell Lymphoma; Mediastinal Large B-cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#Antibody#Phase2#인기#항체+5
효능 ORR 89.5%임상시험 51상태 DISCONTINUED
CGTBiologicProvidence Health & ServicesPhase 1

TCR-transduced T cells (TCR-transduced T cells)

Malignant Epithelial Neoplasms · Malignant Epithelial Neoplasms

#MalignantEpithelialNeoplasms#CGT#Phase1#인기#세포유전치료+4
효능 ORR 0%임상시험 51상태 RECRUITING

17 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기